Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Autoimmune Diseases
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- ? Thalassemia
- AL Amyloidosis
- Aplastic Anemia
- Chronic Kidney Disease
- Chronic Lymphocytic Leukemia (CLL)
- Myelodysplastic Syndrome (MDS)
- Chronic Myelogenous Leukemia (CML)
- Diamond Blackfan Anemia
- Myeloproliferative Disease
- Sickle Cell Anemia
- Hodgkin Disease
- Non-Hodgkin's Lymphoma (NHL)
- Multiple Myeloma
- Myelofibrosis
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01758042
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yi-Bin A Chen, M.D. Director of Clinical Research, Massachusetts General Hospital Bone Marrow Transplant Program